ACM
PMD

Ativo Capital Management’s Psychemedics Corporation PMD Stock Holding History

Ativo Capital Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-46,327
Closed -$854K – 243
2017
Q3 		$854K Sell
46,327
-10,688
-19% -$235K 0.23% 195
2017
Q2 		$1.42M Buy
+57,015
New +$1.2M 0.39% 96

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Ativo Capital Management's PMD Position: Q4 2017 in Review

Ativo Capital Management sold out of Psychemedics Corporation (PMD) in Q4 2017, closing a stake of 46,327 shares — an estimated $854K sold.

Ativo Capital Management first reported a position in PMD in Q2 2017 and held it in 2 quarters. The position peaked at $1.42M in Q2 2017. 46 funds tracked by Wall St. Rank hold PMD as of Q4 2017.

  • Ativo Capital Management reported no remaining Psychemedics Corporation position as of Q4 2017 after selling out during the quarter.
  • Ativo Capital Management sold 46,327 Psychemedics Corporation shares in Q4 2017, an estimated $854K.
  • Ativo Capital Management first reported a position in Psychemedics Corporation in Q2 2017 and held it in 2 quarters.
  • Ativo Capital Management's Psychemedics Corporation position peaked at $1.42M in Q2 2017.
  • 46 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2017.

Based on Ativo Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.